Tinaan, Junel S.
HRN: 23-01-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/06/2023
05/13/2023
IV
600mg
Q6
Osteomyelitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes